Regal Investment Advisors LLC Takes Position in Stericycle Inc (SRCL)

Regal Investment Advisors LLC acquired a new stake in Stericycle Inc (NASDAQ:SRCL) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 30,309 shares of the business services provider’s stock, valued at approximately $2,061,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of SRCL. Mendel Money Management bought a new stake in shares of Stericycle during the 4th quarter worth approximately $619,000. Exchange Capital Management Inc. lifted its holdings in shares of Stericycle by 49.9% during the 4th quarter. Exchange Capital Management Inc. now owns 39,053 shares of the business services provider’s stock worth $2,655,000 after acquiring an additional 13,001 shares during the period. Ironwood Investment Counsel LLC lifted its holdings in shares of Stericycle by 69.0% during the 4th quarter. Ironwood Investment Counsel LLC now owns 13,180 shares of the business services provider’s stock worth $896,000 after acquiring an additional 5,380 shares during the period. Raymond James Trust N.A. lifted its holdings in shares of Stericycle by 61.1% during the 4th quarter. Raymond James Trust N.A. now owns 8,420 shares of the business services provider’s stock worth $573,000 after acquiring an additional 3,194 shares during the period. Finally, Gabelli Funds LLC lifted its holdings in shares of Stericycle by 42.6% during the 4th quarter. Gabelli Funds LLC now owns 159,000 shares of the business services provider’s stock worth $10,810,000 after acquiring an additional 47,500 shares during the period. 95.92% of the stock is owned by hedge funds and other institutional investors.

Stericycle Inc (NASDAQ:SRCL) opened at $72.84 on Thursday. The stock has a market cap of $6,087.94, a P/E ratio of -127.79, a P/E/G ratio of 1.73 and a beta of 0.26. Stericycle Inc has a 12-month low of $61.25 and a 12-month high of $88.00. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million for the quarter, compared to analyst estimates of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. Stericycle’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.24 earnings per share. analysts anticipate that Stericycle Inc will post 4.49 earnings per share for the current year.

In related news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $63.33, for a total transaction of $1,250,957.49. Following the completion of the transaction, the director now directly owns 205,854 shares in the company, valued at approximately $13,036,733.82. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have sold 59,259 shares of company stock valued at $3,847,687. 3.50% of the stock is owned by corporate insiders.

A number of brokerages have recently weighed in on SRCL. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Royal Bank of Canada upped their price target on shares of Stericycle to $75.00 and gave the stock an “underperform” rating in a report on Friday, January 19th. Jefferies Group set a $108.00 price target on shares of Stericycle and gave the stock a “buy” rating in a report on Tuesday, October 17th. BMO Capital Markets reaffirmed a “hold” rating and set a $72.00 price target on shares of Stericycle in a report on Wednesday, January 24th. Finally, Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $73.70.

TRADEMARK VIOLATION NOTICE: “Regal Investment Advisors LLC Takes Position in Stericycle Inc (SRCL)” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.com-unik.info/2018/02/08/regal-investment-advisors-llc-takes-position-in-stericycle-inc-srcl.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit